Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
17.82B | 18.91B | 16.49B | 13.52B | 11.22B | 11.82B | Gross Profit |
4.10B | 4.22B | 3.62B | 2.76B | 2.14B | -210.00M | EBIT |
2.31B | 2.91B | 1.94B | 339.00M | 513.00M | -2.08B | EBITDA |
2.63B | 3.48B | 3.74B | 1.29B | 996.00M | -166.00M | Net Income Common Stockholders |
2.33B | 2.52B | 2.41B | -1.19B | 120.00M | -3.17B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.00B | 5.36B | 3.52B | 2.40B | 2.55B | 3.42B | Total Assets |
31.86B | 35.69B | 31.51B | 29.45B | 28.67B | 29.52B | Total Debt |
4.66B | 5.13B | 5.76B | 5.96B | 7.78B | 7.33B | Net Debt |
-312.00M | -195.00M | 2.25B | 3.58B | 5.24B | 4.02B | Total Liabilities |
32.91B | 36.57B | 35.14B | 35.47B | 33.31B | 34.39B | Stockholders Equity |
-1.07B | -912.00M | -3.68B | -6.05B | -4.66B | -4.90B |
Cash Flow | Free Cash Flow | ||||
2.63B | 2.90B | 1.77B | 1.49B | -587.00M | -3.59B | Operating Cash Flow |
3.02B | 3.78B | 2.48B | 1.85B | -259.00M | -3.01B | Investing Cash Flow |
-753.00M | -831.00M | -726.00M | 826.00M | -428.00M | -1.01B | Financing Cash Flow |
-765.00M | -1.05B | -549.00M | -2.87B | -88.00M | 3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £2.99B | 17.97 | -23.92% | 1.53% | 10.36% | 32.77% | |
66 Neutral | $74.91B | 29.44 | 0.64% | 14.70% | 3.76% | ||
66 Neutral | $4.49B | 12.34 | 5.40% | 248.65% | 4.13% | -12.33% | |
$76.62B | 31.46 | 17.85% | 1.62% | ― | ― | ||
74 Outperform | £5.32B | 27.61 | 44.03% | 0.51% | 3.34% | 481.76% | |
74 Outperform | £1.57B | 40.19 | 11.62% | 1.35% | 8.00% | 674.47% | |
69 Neutral | £709.79M | 27.36 | 5.59% | 1.40% | 1.41% | -16.76% |